Wilcock, G., & Wilkinson, D. (2016). Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type. 661–664.

Wilcock, G., and D. Wilkinson. Galanthamine Hydrobromide: Interim Results of a Group Comparative, Placebo-Controlled Study of Efficacy and Safety in Patients with a Diagnosis of Senile Dementia of the Alzheimer Type. 2016, pp. 661–64.

Wilcock, G, and D Wilkinson. 2016. “Galanthamine Hydrobromide: Interim Results of a Group Comparative, Placebo-Controlled Study of Efficacy and Safety in Patients with a Diagnosis of Senile Dementia of the Alzheimer Type.” In , 661–64.